BlackRock’s Viela Bio, Inc. Common Stock VIE Stock Holding History

BlackRock’s Portfolio VIE Stock Details VIE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,817,537	Closed	-$65.4M	–	5409
2020 Q4	$65.4M	Buy	1,817,537 +520,748	+40%	+$18.2M	﹤0.01%	2316
2020 Q3	$36.4M	Buy	1,296,789 +101,266	+8%	+$3.58M	﹤0.01%	2482
2020 Q2	$51.8M	Buy	1,195,523 +905,785	+313%	+$41M	﹤0.01%	2228
2020 Q1	$11M	Buy	289,738 +25,121	+9%	+$979K	﹤0.01%	2940
2019 Q4	$7.18M	Buy	+264,617	New	+$6.67M	﹤0.01%	3398

BlackRock's VIE Position: Q1 2021 in Review

BlackRock sold out of Viela Bio, Inc. Common Stock (VIE) in Q1 2021, closing a stake of 1,817,537 shares — an estimated $65.4M sold.

BlackRock first reported a position in VIE in Q4 2019 and held it in 5 quarters. The position peaked at $65.4M in Q4 2020. 0 funds tracked by Wall St. Rank hold VIE as of Q1 2021.

BlackRock reported no remaining Viela Bio, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
BlackRock sold 1,817,537 Viela Bio, Inc. Common Stock shares in Q1 2021, an estimated $65.4M.
BlackRock first reported a position in Viela Bio, Inc. Common Stock in Q4 2019 and held it in 5 quarters.
BlackRock's Viela Bio, Inc. Common Stock position peaked at $65.4M in Q4 2020.
0 funds tracked by Wall St. Rank held Viela Bio, Inc. Common Stock as of Q1 2021.

Based on BlackRock's 13F filing for Q1 2021, filed 7 May 2021.